Regeneron Pharmaceuticals, Inc. Shares Outstanding 2008–2025
Regeneron Pharmaceuticals, Inc. reported 0.0M of shares outstanding for fiscal 2025. The filed year-end share count was broadly unchanged.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 0.0M | — |
| FY 2024 | 0.0M | — |
| FY 2023 | 0.0M | — |
| FY 2022 | 0.0M | — |
| FY 2021 | 0.0M | — |
| FY 2020 | 0.0M | — |
| FY 2019 | 0.0M | — |
| FY 2018 | 0.0M | — |
| FY 2017 | 0.0M | — |
| FY 2016 | 0.0M | — |
| FY 2015 | 0.0M | — |
| FY 2014 | 0.0M | — |
| FY 2013 | 0.0M | — |
| FY 2012 | 0.0M | -100.0% |
| FY 2011 | 90.7M | +4.0% |
| FY 2010 | 87.2M | +10.6% |
| FY 2009 | 78.9M | — |
| FY 2008 | 0.0M | — |
Source: Regeneron Pharmaceuticals, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open REGN 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Regeneron Pharmaceuticals, Inc. reported 0.0M of shares outstanding for fiscal 2025. The filed year-end share count was broadly unchanged. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Regeneron Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeRegeneron Pharmaceuticals, Inc. — frequently asked questions
What is Regeneron Pharmaceuticals, Inc.'s shares outstanding?
Regeneron Pharmaceuticals, Inc. (REGN) reported shares outstanding of 0.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Regeneron Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More REGN financial history
Full REGN fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →